Indivior Pharmaceuticals, Inc. (INDV)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 150M 300M 450M Q1 '24: 284M Q2 '24: 299M Q3 '24: 307M Q4 '24: 299M Q1 '25: 266M Q2 '25: 302M Q3 '25: 314M Q4 '25: 358M Q1 '26: 317M Q2 '26: 343M Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Gross Profit Quarterly

0 100M 200M 300M Q1 '24: 246M Q2 '24: 220M Q3 '24: 241M Q4 '24: 250M Q1 '25: 221M Q2 '25: 250M Q3 '25: 230M Q4 '25: 292M Q1 '26: 277M Q2 '26: 294M Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating Income Quarterly

-120M -60M 0 60M 120M 180M Q1 '24: 75M Q2 '24: -118M Q3 '24: 35M Q4 '24: 46M Q1 '25: 66M Q2 '25: 72M Q3 '25: 43M Q4 '25: 81M Q1 '26: 137M Q2 '26: 160M Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Net Income Quarterly

-100M -50M 0 50M 100M 150M Q1 '24: 61M Q2 '24: -97M Q3 '24: 22M Q4 '24: 21M Q1 '25: 47M Q2 '25: 18M Q3 '25: 42M Q4 '25: 102M Q1 '26: 89M Q2 '26: 122M Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Cost of Revenue Quarterly

0 30M 60M 90M Q1 '24: 38M Q2 '24: 79M Q3 '24: 66M Q4 '24: 48M Q1 '25: 44M Q2 '25: 52M Q3 '25: 83M Q4 '25: 67M Q1 '26: 40M Q2 '26: 50M Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating Cash Flow Quarterly

-240M -160M -80M 0 80M 160M 240M Q1 '24: -37M Q2 '24: 88M Q3 '24: 2M Q4 '24: -17M Q1 '25: 75M Q2 '25: 158M Q3 '25: -39M Q4 '25: -221M Q1 '26: -9M Q2 '26: 229M Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Free Cash Flow Quarterly

-270M -180M -90M 0 90M 180M 270M Q1 '24: -39M Q2 '24: 84M Q3 '24: -5M Q4 '24: -33M Q1 '25: 70M Q2 '25: 141M Q3 '25: -59M Q4 '25: -245M Q1 '26: -29M Q2 '26: 222M Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 50M 100M 150M Q1 '24: 137M Q2 '24: 135M Q3 '24: 133M Q1 '25: 125M Q2 '25: 126M Q3 '25: 129M Q1 '26: 129M Q2 '26: 124M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.00 0.00 1.00 2.00 3.00 Q4 '24: 0.05 Q1 '25: -0.02 Q2 '25: 0.84 Q3 '25: 1.01 Q4 '25: 1.64 Q1 '26: 1.95 Q2 '26: 2.79 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.